Abstract

Background: Patient-reported outcome (PRO) measures historically used in inflammatory bowel disease have been considered inadequate to support future drug labelling claims by regulatory agencies.

Tags

Psychometrics, Crohn's Disease, Ulcerative Colitis, Pathology, Psychology, Health Impact Assessment, Outcome Assessment

Read More